0001710072-20-000001.txt : 20201210 0001710072-20-000001.hdr.sgml : 20201210 20201210144238 ACCESSION NUMBER: 0001710072-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201210 DATE AS OF CHANGE: 20201210 EFFECTIVENESS DATE: 20201210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-382855 FILM NUMBER: 201380317 BUSINESS ADDRESS: STREET 1: C/O ORBIMED ADVISORS LLC STREET 2: 601 LEXINGTON AVE, 54TH FLR. CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-739-6451 MAIL ADDRESS: STREET 1: C/O ORBIMED ADVISORS LLC STREET 2: 601 LEXINGTON AVE, 54TH FLR. CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001710072 Edgewise Therapeutics, Inc. 3415 Colorado Ave Boulder CO COLORADO 80303 (303) 735-8373 DELAWARE None None Corporation true 2017 Kevin Koch 3415 Colorado Ave Boulder CO COLORADO 80303 Executive Officer Director Peter Thompson 3415 Colorado Ave Boulder CO COLORADO 80303 Director Kenneth Harrison 3415 Colorado Ave Boulder CO COLORADO 80303 Director Jonathan Root 3415 Colorado Ave Boulder CO COLORADO 80303 Director Alan Russell 3415 Colorado Ave Boulder CO COLORADO 80303 Director Biotechnology Decline to Disclose 06b false 2020-12-03 false true false 0 95000000 95000000 0 false 21 0 0 0 true false Edgewise Therapeutics, Inc. Jill Fishbein Jill Fishbein Secretary 2020-12-08